Ixazomib, thalidomide, & dexamethasone (ITD) re-induction
HM16/047
Phase 3 small_molecule active
Quick answer
Ixazomib, thalidomide, & dexamethasone (ITD) re-induction for Multiple Myeloma is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Multiple Myeloma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active